Picture biomindz TRON LSG Mainz Translation Cancer Immunotherapy 650x100px

Organisation › Details

EIT Health e.V.

https://www.eithealth.eu

LinkedIn: https://www.linkedin.com/company/eithealth

	Start	2021-11-09 existent
	Group	EU (govt)
	Industry	business development (state/region)
	Industry 2	HEALTH (HUMAN)

	Region	München (Munich)
	Country	Germany
	Street	1C Mies-van-der-Rohe-Str.
	City	80807 München
	Tel	+49-89-215-474-820
		Address record changed: 2024-01-05

Basic data	Employees	n. a.


		Record changed: 2024-10-19

Picture biomindz Mainz Biomed LSG Colorectal Cancer Screening 650x200px

More documents for EU (govt)

[1] Pentixapharm Holding AG. (8/26/24). "Press Release: Pentixapharm AG Receives Orphan Drug Designation for its Radiodiagnostic Tracer PentixaFor in Marginal Zone Lymphoma by the European Medicines Agency". Berlin & Würzburg....
[2] Protembis GmbH. (7/30/24). "Press Release: German Medtech Protembis Gets €20 million EIB Backing for Technology to Protect Brain during Heart Treatment". Luxembourg & Aachen....
[3] Boehringer Ingelheim. (7/29/24). "Press Release: CHMP Adopts Positive Opinion Recommending Approval of New and Expanded Indications for Spevigo". Ingelheim & La Jolla, CA....
[4] Nyxoah S.A.. (7/3/24). "Press Release: Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank". Mont-Saint-Guibert....
[5] Valneva S.E.. (7/1/24). "Press Release: Valneva Receives Marketing Authorization in Europe for the World’s First Chikungunya Vaccine, Ixchiq". Saint Herblain....
[6] CRISPR Therapeutics AG. (2/13/24). "Press Release: European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, Casgevy (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT)". Z...
[7] SolasCure Ltd.. (11/3/23). "Press Release: SolasCure Awarded Prestigious European Innovation Council’s Accelerator Grant"....
[8] Roche. (10/30/23). "Press Release: Roche Announces EMBARK Trial in Duchenne Muscular Dystrophy (DMD) Did Not Reach Primary Endpoint, but Shows Positive Efficacy Outcomes on All Timed Functional Key Endpoints". Basel....
[9] Valneva S.E.. (10/25/23). "Press Release: Valneva Submits Chikungunya Vaccine Marketing Application to EMA and Announces CHMP Accelerated Assessment". Saint Herblain....
[10] 4SC AG. (10/18/23). "Press Release: 4SC Receives Orphan Drug Designation (ODD) for Resminostat (Kinselby) in CTCL in the European Union". Planegg-Martinsried....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)